According to Ojing Medical's announcement, the cumulative deviation value of the closing price drop of the company's stock over 10 consecutive trading days exceeded 50%, which is a serious abnormal fluctuation in stock trading. After self-inspection and verification, Eric Gang Hu, the largest shareholder, showed that as of the date of disclosure of the announcement, there were no important matters that should have been disclosed but not disclosed, and directors and supervisors did not trade the company's shares during the period of abnormal fluctuations. The company needs to review prior financial data or correction of accounting errors, and is unable to disclose the report for the third quarter of 2026 as scheduled; the company has been investigated by the China Securities Regulatory Commission. If a major illegal forced delisting situation is encountered, the company's shares will be subject to major illegal forced delisting. Investors are kindly requested to pay attention to investment risks.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.